Vitreous Incarceration After Ranibizumab Injection: An Ultrasound Biomicroscopy Study

Basit Öğe Kaydı
dc.contributor.authorHelvaci, Sezer
dc.contributor.authorSahinoglu-Keskek, Nedime
dc.contributor.authorKiziloglu, Mustafa
dc.contributor.authorOksuz, Huseyin
dc.contributor.authorCevher, Selim
dc.date.accessioned2024-09-18T21:06:39Z
dc.date.available2024-09-18T21:06:39Z
dc.date.issued2015
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.description.abstractBACKGROUND AND OBJECTIVE: The aim of the study was to evaluate vitreous incarceration at the injection site using ultrasound biomicroscopy (UBM) after intravitreal injection of ranibizumab. PATIENTS AND METHODS: The study included 39 eyes of 34 patients who underwent intravitreal injection of 0.05 mL of ranibizumab. UBM (HiScan; Optikon, Rome, Italy) with a 50 MHz probe was performed 1 day after surgery to determine the existence of vitreous incarceration at the injection site. RESULTS: The mean patient age was 59.7 (+/- 10.1) years, and 58.9% were female. Vitreous incarceration into the pars plana site was detected in six eyes (15.3%) the day after intravitreal injection. CONCLUSION: Vitreous incarceration at the injection site after intravitreal injection is thought to lead to a higher risk for complications such as infection, retinal breaks, retinal detachment, vitreous hemorrhage, and fibrovascular proliferation at the injection site. To understand the clinical importance of vitreous incarceration, further long-term prospective studies are necessary.en_US
dc.identifier.doi10.3928/23258160-20150422-11
dc.identifier.endpage474en_US
dc.identifier.issn2325-8160
dc.identifier.issn2325-8179
dc.identifier.issue4en_US
dc.identifier.pmid25932725en_US
dc.identifier.scopus2-s2.0-84929406102en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage471en_US
dc.identifier.urihttps://doi.org/10.3928/23258160-20150422-11
dc.identifier.urihttps://hdl.handle.net/20.500.12483/13746
dc.identifier.volume46en_US
dc.identifier.wosWOS:000359292300011en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSlack Incen_US
dc.relation.ispartofOphthalmic Surgery Lasers & Imaging Retinaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectPars-Plana Vitrectomyen_US
dc.subjectIntraocular-Pressure Changesen_US
dc.subjectIntravitreal Triamcinolone Acetonideen_US
dc.subjectSclerotomy Sitesen_US
dc.subject25-Gauge Vitrectomyen_US
dc.subjectMacular Degenerationen_US
dc.subjectHemorrhageen_US
dc.subjectBevacizumaben_US
dc.subjectLucentisen_US
dc.subjectRetinaen_US
dc.titleVitreous Incarceration After Ranibizumab Injection: An Ultrasound Biomicroscopy Studyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu